InsidersTradesSigma
Discover the full record of transactions filed by 홍성상, Chief Executive Officer. Insider active across 2 companies, notably 경보제약. In total, 7 filings have been logged. Activity tracked since 5 March 2026. The latest transaction was disclosed on 17 March 2026 (Purchase). Regulator: DART (FSS). The full history is openly available.
7 of 7 declarations
Hong Sung-Sang is the Managing Director of 경보제약, a pharmaceutical company. In this role, he oversees operations and research projects, contributing to the innovation and growth of the company. His expertise is essential for the success of strategic initiatives.